General Information
Version
24/06/2025
Revision date
2025-06-24
Product name
SSPE Buffer tablets
Emergency telephone
0344 892 0111, 0845 4647
Icons in SDS
Company Information
company name
Medicago AB
e-mail address of the competent person responsible for the Safety Data Sheet
info@medicago.se
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H315, H319, H335
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
Signal word
Warning
Hazard statements
Causes skin irritation. (H315) Causes serious eye irritation. (H319) May cause respiratory irritation. (H335)
Precautionary statements
General -
Prevention
Wash hands thoroughly after handling. (P264) Wear eye protection/protective gloves/protective clothing. (P280)
Response
IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. (P305+P351+P338) If eye irritation persists: Get medical advice/attention. (P337+P313)
Storage
Store in a well-ventilated place. Keep container tightly closed. (P403+P233)
Disposal
Dispose of contents/container in accordance with local regulation. (P501)
Hazardous Ingredients
Ethylenediaminetetraacetic acid disodium salt dihydrate (EDTA disodium salt dihydrate)
2.3 Other hazards
Additional warnings This mixture/product does not contain any substances known to fulfil the criteria for PBT and vPvB classification. This product does not contain any substances considered to be endocrine disruptors in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2023/707.
2.1 Classification of the substance or mixture
Skin Irrit. 2; H315, Causes skin irritation. Eye Irrit. 2; H319, Causes serious eye irritation. STOT SE 3; H335, May cause respiratory irritation.
